211 related articles for article (PubMed ID: 12240692)
1. Aspirin for the primary prevention of coronary events.
Mascitelli L; Pezzetta F
N Engl J Med; 2002 Sep; 347(12):948; author reply 948. PubMed ID: 12240692
[No Abstract] [Full Text] [Related]
2. Clinical practice. Aspirin for primary prevention of coronary events.
Lauer MS
N Engl J Med; 2002 May; 346(19):1468-74. PubMed ID: 12000818
[No Abstract] [Full Text] [Related]
3. Aspirin in the prevention of cardiovascular disease in women.
Schwartz DJ
N Engl J Med; 2005 Jun; 352(26):2751-2; author reply 2751-2. PubMed ID: 15987927
[No Abstract] [Full Text] [Related]
4. Aspirin for the primary prevention of coronary events.
Mehta JL
N Engl J Med; 2002 Sep; 347(12):948; author reply 948. PubMed ID: 12239271
[No Abstract] [Full Text] [Related]
5. Aspirin use for prevention of CHD: an FP's story.
Miser WF
Am Fam Physician; 2005 Jan; 71(2):250-1, 253. PubMed ID: 15686298
[No Abstract] [Full Text] [Related]
6. Effective platelet inhibition by aspirin and clopidogrel: where are we now?
Tousoulis D; Briasoulis A; Dhamrait SS; Antoniades C; Stefanadis C
Heart; 2009 May; 95(10):850-8. PubMed ID: 19401288
[No Abstract] [Full Text] [Related]
7. Aspirin for the primary prevention of cardiovascular events.
Ferrini R; Clark B
Am Fam Physician; 2002 Nov; 66(9):1737-8. PubMed ID: 12449273
[No Abstract] [Full Text] [Related]
8. Aspirin and heart disease.
Nurse Pract; 1996 Nov; 21(11):111-2. PubMed ID: 8933540
[No Abstract] [Full Text] [Related]
9. Aspirin for primary prevention. Doctors and patients should understand potential benefits and risks of aspirin treatment.
Alkhenizan A
BMJ; 2000 Dec; 321(7274):1472-3. PubMed ID: 11187951
[No Abstract] [Full Text] [Related]
10. Kawasaki disease.
Shulman ST; Bendet M
Compr Ther; 1997 Jan; 23(1):13-8. PubMed ID: 9067077
[No Abstract] [Full Text] [Related]
11. Aspirin for prevention of myocardial infarction.
Mirvis DM
J Tenn Med Assoc; 1995 Oct; 88(10):392-4. PubMed ID: 7475013
[No Abstract] [Full Text] [Related]
12. [Aspirin in secondary cardiovascular prevention: from clinical studies to daily practice].
Garnier LF
Ann Cardiol Angeiol (Paris); 1997 Oct; 46(8):507-12. PubMed ID: 9538362
[TBL] [Abstract][Full Text] [Related]
13. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
Toth PP
Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet therapy and atherosclerotic events. Risks and patients' values need to be included in decision about aspirin for prevention of coronary heart disease.
Pignone M; Mulrow C
BMJ; 2002 Apr; 324(7342):917. PubMed ID: 11951911
[No Abstract] [Full Text] [Related]
15. [Primary prevention of coronary heart disease with aspirin].
Kübler W
Z Kardiol; 2004; 93 Suppl 2():II33-6. PubMed ID: 15021994
[TBL] [Abstract][Full Text] [Related]
16. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.
Bartolucci AA; Howard G
Am J Cardiol; 2006 Sep; 98(6):746-50. PubMed ID: 16950176
[TBL] [Abstract][Full Text] [Related]
18. [After the disappointing ASS primary prevention trial. "Holding back in women"].
Rupprecht HJ
MMW Fortschr Med; 2005 Mar; 147(12):13. PubMed ID: 15832783
[No Abstract] [Full Text] [Related]
19. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
[TBL] [Abstract][Full Text] [Related]
20. [Female, young, healthy. ASS does not protect from myocardial infarct].
MMW Fortschr Med; 2005 Mar; 147(12):10. PubMed ID: 15832782
[No Abstract] [Full Text] [Related]
[Next] [New Search]
